2m 2m 2m 2m 2m 2m 2m
BRIDGEBIO PHARMA (BBIO)
NASDAQ
$68.02-$0.11 (-0.15%)
Price as of Oct 22, 2026 7:36 PM EDT- $13.2BMarket Cap
- 27.24%1-Year Change
- BiotechnologyIndustry
BRIDGEBIO PHARMA (BBIO)
$68.02-$0.11 (-0.15%)
BBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $68.12 | ||
Change | +$0.19 (+0.28%) | ||
Open | $67.48 | ||
High | $69.32 | ||
Low | $67.07 | ||
Previous Close | $67.74 | ||
Volume | 2,780,421 | ||
30-Day Average Volume | 2,855,322 | ||
1-Week Change | 4.31% | ||
1-Month Change | 1.74% | ||
1-Year Change | 27.24% | ||
3-Year Change | 175.70% | ||
5-Year Change | 46.85% | ||
Fundamentals | |||
Shares Outstanding | 195.5M | ||
Total Assets | $1.2B | ||
Market Cap | $13.2B | ||
Enterprise Value | $13.1B | ||
Period: QTR TTM FY | |||
Revenue | $222.4M | ||
Net Income | -$155.9M | ||
Free Cash Flow | -$71.5M | ||
EBIT | -$152.0M | ||
EBITDA | -$150.9M | ||
Net Working Capital | $202.5M | ||
EPS | -$0.78 | ||
Enterprise Value/EBITDA | -87 | ||
Enterprise Value/Revenue | 59 | ||
P/B | -5 | ||
P/E | -87 | ||
PEG | -12 | ||
Price/Free Cash Flow | -185 | ||
Price/Operating Cash Flow | -186 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue